EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 96 filers reported holding EPIZYME INC in Q2 2022. The put-call ratio across all filers is 5.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $43,000 | -10.4% | 37,398 | +94.1% | 0.00% | – |
| Q4 2021 | $48,000 | -52.0% | 19,264 | -0.9% | 0.00% | -100.0% |
| Q3 2021 | $100,000 | -37.9% | 19,444 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $161,000 | -10.6% | 19,368 | -6.4% | 0.00% | -50.0% |
| Q1 2021 | $180,000 | -19.6% | 20,699 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $224,000 | -12.2% | 20,600 | -3.5% | 0.00% | -33.3% |
| Q3 2020 | $255,000 | -0.4% | 21,345 | +34.1% | 0.00% | -25.0% |
| Q2 2020 | $256,000 | -3.4% | 15,921 | -6.9% | 0.00% | -20.0% |
| Q1 2020 | $265,000 | – | 17,105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |